Citation: Jbd. Palmer et al., PLACEBO-CONTROLLED TRIALS OF ONDANSETRON FOR POSTOPERATIVE NAUSEA ANDVOMITING, BMJ. British medical journal, 312(7024), 1996, pp. 183-183
Citation: Mab. Devoy et al., ARE THERE ANY DETRIMENTAL EFFECTS OF THE USE OF INHALED LONG-ACTING BETA(2)-AGONISTS IN THE TREATMENT OF ASTHMA, Chest, 107(4), 1995, pp. 1116-1124
Citation: L. Fjellbirkeland et al., THE EFFICACY AND TOLERABILITY OF INHALED SALMETEROL AND INDIVIDUALLY DOSE-TITRATED, SUSTAINED-RELEASE THEOPHYLLINE IN PATIENTS WITH REVERSIBLE AIRWAYS DISEASE, Respiratory medicine, 88(8), 1994, pp. 599-607
Citation: Jbd. Palmer et Jm. Oxford, SALMETEROL XINAFOATE IN ASTHMA, JAMA, the journal of the American Medical Association, 272(20), 1994, pp. 1575-1575
Citation: Rw. Fuller et al., BRONCHODILATOR TREATMENT IN ASTHMA - INCREASE IN DEATHS DURING SALMETEROL TREATMENT UNEXPLAINED - REPLY, BMJ. British medical journal, 306(6892), 1993, pp. 1611-1611
Citation: Dm. Newnham et al., SALMETEROL PROVIDES PROLONGED PROTECTION AGAINST EXERCISE-INDUCED BRONCHOCONSTRICTION IN A MAJORITY OF SUBJECTS WITH MILD, STABLE ASTHMA, Respiratory medicine, 87(6), 1993, pp. 439-444